Table 1.
Variables | Whole Population | NTN‐nAC (n=54, 25%) | HTN (n=93, 42%) | NTN‐rAC (n=73, 33%) | P Value |
---|---|---|---|---|---|
Clinical data | |||||
Age, y | 69±13 | 59±14a, b | 73±10c | 72±9c | <0.0001 |
Male sex, % | 71 | 62 | 76 | 70 | 0.20 |
Body mass index, kg/m2 | 28±5 | 27±5 | 29±5 | 27±4 | 0.07 |
Body surface area, m2 | 1.86±0.21 | 1.84±0.22 | 1.89±0.21 | 1.83±0.20 | 0.36 |
Blood pressure: systolic, mm Hg | 135±18 | 114±10a, b | 152±11c, b | 129±7a, c | <0.0001 |
Blood pressure: diastolic, mm Hg | 74±10 | 72±10a | 79±11c, b | 69±8a | <0.0001 |
Coronary artery disease, % | 45 | 19a, b | 50 | 56 | <0.0001 |
Diabetes mellitus, % | 25 | 21 | 28 | 22 | 0.52 |
Renal failure, % | 12 | 8 | 14 | 12 | 0.58 |
Echocardiographic data | |||||
Peak aortic jet velocity, m/s | 3.42±0.88 | 3.72±1.12a, b | 3.24±0.70c | 3.43±0.85c | 0.006 |
Mean gradient, mm Hg | 29±18 | 36±24a, b | 25±12c | 29±17c | 0.001 |
Aortic valve area, cm2 | 1.06±0.30 | 1.07±0.33 | 1.12±0.29b | 1.08±0.27a | 0.005 |
Indexed aortic valve area, cm2/m2 | 0.57±0.16 | 0.59±0.18 | 0.59±0.15b | 0.52±0.13a | 0.009 |
Stroke volume, mL | 82±17 | 88±19b | 84±17b | 76±11a, c | 0.0001 |
Indexed stroke volume, mL/m2 | 44±7 | 48±8a, b | 45±8c, b | 41±5a, c | <0.0001 |
LV ejection fraction, % | 65±6 | 65±6 | 65±7 | 64±6 | 0.80 |
Multidetector computed tomography data | |||||
Aortic valve calcification, AU | 1677 [1466–1889] | 1795 [1364–2260] | 1665 [1340–1990] | 1607 [1240–1975] | 0.81d |
Aortic valve calcification density, AU/cm2 | 374 [323–426] | 418 [313–524] | 354 [274–433] | 369 [279–458] | 0.62d |
AU indicates Agatston units; HTN, hypertensive group; LV, left ventricle; NTN‐nAC, nonhypertensive–normal arterial compliance group; NTN‐rAC, nonhypertensive–reduced arterial compliance group.
P<0.05 from hypertension patients.
P<0.05 from NTN‐rAC patients.
P<0.05 from NTN‐nAC patients.
Statistical analysis stratified for sex.